Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

All research papers

2996 approved papers, newest first · showing 1921–1980.Search instead →

  1. 23 Jun 2021· The New England journal of medicine· Ga-68 PSMA PET· Therapeutic· Theranostic
    Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
    Sartor O et al.
  2. 20 Jun 2021· Journal of applied clinical medical physics· Linac QA· QA & dosimetry· Free full text
    Commissioning of and preliminary experience with a new fully integrated computed tomography linac.
    Yu L et al.
  3. 18 Jun 2021· Pharmaceutics· Ac-225 alpha therapy· Therapeutic· Free full text
    Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight".
    Eychenne R et al.
  4. 17 Jun 2021· European journal of nuclear medicine and molecular imaging· Lu-177 FAPI· Diagnostic· Free full text
    Head-to-head intra-individual comparison of biodistribution and tumor uptake of ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT in cancer patients.
    Giesel FL et al.
  5. 29 May 2021· European journal of nuclear medicine and molecular imaging· Lu-177 FAPI· Diagnostic· Free full text
    ⁶⁸Ga-FAPI-PET/CT in patients with various gynecological malignancies.
    Dendl K et al.
  6. 27 May 2021· Surgical endoscopy· Radio-guided & fluorescence-guided surgery· Diagnostic· Free full text
    Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green.
    Overwater A et al.
  7. 14 May 2021· Medical physics· Linac QA· QA & dosimetry
    Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT preclinical animal experiments and future clinical human protocols.
    Moeckli R et al.
  8. 13 May 2021· Radiation oncology (London, England)· Breast / lung positioning· Therapeutic· Free full text
    Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility.
    Gaál S et al.
  9. 2 May 2021· Annals of nuclear medicine· Lu-177 FAPI· Diagnostic
    ⁶⁸Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the ¹⁸F-FDG PET/CT.
    Kömek H et al.
  10. 1 May 2021· Journal of radiation research· Personal / occupational dosimetry· Radiation safety· Free full text
    Evaluation of novel X-ray protective eyewear in reducing the eye dose to interventional radiology physicians.
    Endo M et al.
  11. 21 Apr 2021· Pharmaceutics· Cyclotron production· Therapeutic· Free full text
    Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.
    Ahenkorah S et al.
  12. 16 Apr 2021· Radiation and environmental biophysics· TLD dosimetry· Radiation safety· Free full text
    Application of Bayesian statistics for radiation dose assessment in mixed beta-gamma fields.
    Słonecka I et al.
  13. 16 Apr 2021· Journal of nuclear medicine· Lu-177 FAPI· Diagnostic
    ⁶⁸Ga-DOTA-FAPI-04 PET/MR in the Evaluation of Gastric Carcinomas: Comparison with ¹⁸F-FDG PET/CT.
    Qin C et al.
  14. 7 Apr 2021· Pharmaceutics· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with ⁶⁸Ga and ¹⁷⁷Lu as Potential Theranostic Agent for Colon Cancer.
    Leonte RA et al.
  15. 1 Apr 2021· Medical physics· SRS / intracranial· QA & dosimetry
    Treatment planning system and beam data validation for the ZAP-X: A novel self-shielded stereotactic radiosurgery system.
    Srivastava SP et al.
  16. 1 Apr 2021· Medical physics· Linac QA· QA & dosimetry· Free full text
    Machine QA for the Elekta Unity system: A Report from the Elekta MR-linac consortium.
    Roberts DA et al.
  17. 31 Mar 2021· Journal of applied clinical medical physics· 6DoF head positioning· QA & dosimetry· Free full text
    Accuracy of surface-guided patient setup for conventional radiotherapy of brain and nasopharynx cancer.
    Lee SK et al.
  18. 23 Mar 2021· Medical physics· Linac QA· QA & dosimetry
    AAPM Task Group 264: The safe clinical implementation of MLC tracking in radiotherapy.
    Keall PJ et al.
  19. 12 Mar 2021· Journal of nuclear medicine· Ga-68 PSMA PET· Diagnostic
    Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer.
    Farolfi A et al.
  20. 3 Mar 2021· Journal of applied clinical medical physics· 6DoF head positioning· QA & dosimetry· Free full text
    Intra-fractional patient motion when using the Qfix Encompass immobilization system during HyperArc treatment of patients with brain metastases.
    Komiyama R et al.
  21. 26 Feb 2021· The Journal of urology· Ga-68 PSMA PET· Diagnostic· Free full text
    A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with ¹⁸F-DCFPyL in Prostate Cancer Patients (OSPREY).
    Pienta KJ et al.
  22. 23 Feb 2021· Clinical cancer research· Ga-68 PSMA PET· Diagnostic
    Diagnostic Performance of ¹⁸F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.
    Morris MJ et al.
  23. 19 Feb 2021· European journal of nuclear medicine and molecular imaging· Ga-68 PSMA PET· Diagnostic· Free full text
    E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.
    Ceci F et al.
  24. 16 Feb 2021· Strahlentherapie und Onkologie· In-vivo dosimetry· QA & dosimetry
    Improving dose delivery accuracy with EPID in vivo dosimetry: results from a multicenter study.
    Esposito M et al.
  25. 12 Feb 2021· European journal of cancer (Oxford, England· Ga-68 DOTATATE· Diagnostic· Therapeutic
    Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
    Ambrosini V et al.
  26. 11 Feb 2021· Lancet (London, England)· Ga-68 PSMA PET· Therapeutic· Theranostic
    [¹⁷⁷Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
    Hofman MS et al.
  27. 25 Jan 2021· The Lancet. Rheumatology· Lu-177 FAPI· Diagnostic
    ⁶⁸Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study.
    Bergmann C et al.
  28. 11 Jan 2021· International journal of radiation oncology, biology, physics· OSL dosimetry· QA & dosimetry
    Electron FLASH Delivery at Treatment Room Isocenter for Efficient Reversible Conversion of a Clinical LINAC.
    Rahman M et al.
  29. 9 Jan 2021· Cancers· Gold-anchor fiducial markers· Therapeutic· Free full text
    Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation.
    Iwata H et al.
  30. 7 Jan 2021· EJNMMI radiopharmacy and chemistry· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators.
    Fersing C et al.
  31. 7 Jan 2021· EJNMMI radiopharmacy and chemistry· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE.
    Thisgaard H et al.
  32. 1 Jan 2021· Technology in cancer research & treatment· Breast / lung positioning· QA & dosimetry· Free full text
    Compare of Interfractional Setup Reproducibility Between Vacuum-Lock Bag and Thermoplastic Mask in Radiotherapy for Breast Cancer.
    Song Y et al.
  33. 31 Dec 2020· Pharmaceutics· Cyclotron production· Therapeutic· Radiopharmacy· Free full text
    Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications.
    Nelson BJB et al.
  34. 18 Dec 2020· Physics and imaging in radiation oncology· Adaptive radiotherapy· Therapeutic· Free full text
    Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region.
    Sibolt P et al.
  35. 17 Dec 2020· EJNMMI radiopharmacy and chemistry· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Fully-automated production of [⁶⁸Ga]Ga-FAPI-46 for clinical application.
    Spreckelmeyer S et al.
  36. 16 Dec 2020· International journal of radiation oncology, biology, physics· Adaptive radiotherapy· Therapeutic· QA & dosimetry
    Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    McDonald BA et al.
  37. 5 Dec 2020· European urology· Ac-225 alpha therapy· Therapeutic
    Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
    Feuerecker B et al.
  38. 1 Dec 2020· Nuclear medicine communications· Hot-lab shielding· Radiation safety
    Safe practice ventilation technique in lung scanning for pulmonary embolism.
    Mayes CD.
  39. 1 Dec 2020· Radiology· Lu-177 FAPI· Diagnostic
    Comparison of ⁶⁸Ga-FAPI and ¹⁸F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers.
    Pang Y et al.
  40. 26 Nov 2020· European journal of nuclear medicine and molecular imaging· Lu-177 FAPI· Diagnostic
    Biodistribution, pharmacokinetics, dosimetry of [⁶⁸Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [¹⁸F]F-FDG PET/CT in patients with various cancers.
    Ballal S et al.
  41. 11 Nov 2020· European journal of nuclear medicine and molecular imaging· Lu-177 FAPI· Diagnostic
    Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [⁶⁸Ga]Ga-FAPI-04 PET/CT versus MRI and [¹⁸F]-FDG PET/CT.
    Guo W et al.
  42. 1 Nov 2020· Nuclear medicine communications· Hot-lab shielding· Radiation safety
    Management and evaluation of sodium [131I] iodide contamination after oral administration.
    Labbe E et al.
  43. 30 Oct 2020· Journal of nuclear medicine· Lu-177 FAPI· Diagnostic
    The Latest Developments in Imaging of Fibroblast Activation Protein.
    Altmann A et al.
  44. 29 Oct 2020· Journal of applied clinical medical physics· 6DoF head positioning· QA & dosimetry· Free full text
    Effect of setup error in the single-isocenter technique on stereotactic radiosurgery for multiple brain metastases.
    Nakano H et al.
  45. 24 Oct 2020· International journal of radiation oncology, biology, physics· Adaptive radiotherapy· QA & dosimetry· Therapeutic
    Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology.
    Glide-Hurst CK et al.
  46. 24 Oct 2020· European journal of nuclear medicine and molecular imaging· Lu-177 FAPI· Diagnostic
    Comparison of PET imaging of activated fibroblasts and ¹⁸F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study.
    Shi X et al.
  47. 23 Oct 2020· Journal of nuclear medicine· Lu-177 FAPI· Diagnostic
    Impact of ⁶⁸Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas.
    Röhrich M et al.
  48. 17 Oct 2020· Radiotherapy and oncology· Adaptive radiotherapy· Therapeutic· QA & dosimetry
    A deep learning approach to generate synthetic CT in low field MR-guided adaptive radiotherapy for abdominal and pelvic cases.
    Cusumano D et al.
  49. 2 Oct 2020· Radiotherapy and oncology· MR-linac / MR-guided· QA & dosimetry
    ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium.
    Kooreman ES et al.
  50. 1 Oct 2020· Occupational medicine (Oxford, England)· Personal / occupational dosimetry· Radiation safety
    Occupational low-dose irradiation and cancer risk among medical radiation workers.
    Chartier H et al.
  51. 1 Oct 2020· Physics and imaging in radiation oncology· In-vivo dosimetry· QA & dosimetry· Free full text
    Evaluation of automated pre-treatment and transit in-vivo dosimetry in radiotherapy using empirically determined parameters.
    Bossuyt E et al.
  52. 29 Sept 2020· Frontiers in artificial intelligence· Patient-specific QA· QA & dosimetry· Free full text
    Integration of AI and Machine Learning in Radiotherapy QA.
    Chan MF et al.
  53. 22 Sept 2020· Radiotherapy and oncology· Adaptive radiotherapy· Therapeutic
    Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
    Intven MPW et al.
  54. 17 Sept 2020· Nature communications· TLD dosimetry· Radiation safety· Free full text
    In vivo localization of chronically implanted electrodes and optic fibers in mice.
    Király B et al.
  55. 17 Sept 2020· Radiotherapy and oncology· Vacuum cushions· QA & dosimetry
    Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases.
    Werensteijn-Honingh AM et al.
  56. 16 Sept 2020· Practical radiation oncology· Adaptive radiotherapy· Therapeutic
    Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer.
    Chuong MD et al.
  57. 11 Sept 2020· International journal of radiation oncology, biology, physics· SRS / intracranial· Therapeutic
    Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT et al.
  58. 7 Sept 2020· Frontiers in oncology· Adaptive radiotherapy· Therapeutic· Free full text
    The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.
    de Mol van Otterloo SR et al.
  59. 2 Sept 2020· Molecules (Basel, Switzerland)· Ga-68 DOTATATE· Diagnostic· Therapeutic· Free full text
    Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy.
    Eychenne R et al.
  60. 21 Aug 2020· Journal of clinical oncology· SBRT delivery· Therapeutic
    Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.
    McBride S et al.